Article
Cross talk between drug‐resistant epilepsy and the gut microbiome
2 Nov 2020
Abstract excerpt
One-third of epilepsy patients have drug-resistant epilepsy (DRE), which is often complicated by polydrug toxicity and psychiatric and cognitive comorbidities. Advances in understanding the microbiome and gut-brain-axis are likely to shed light on epilepsy pathogenesis, anti-seizure medication (ASM) resistance, and potential therapeutic targets. Gut dysbiosis is associated with inflammation, blood-brain barrier...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
